Virtual healthcare company Teladoc Health (NYSE: TDOC) thrived in 2020 when telehealth medical appointments were the sole option available to patients during the lockdown.

Teladoc, like every other growth stock that has been hammered this year, has had to bear the brunt of it. Investors are concerned that Teladoc's business will not survive in the post-pandemic market. Telehealth services will be in less demand now that hospitals and medical facilities have reopened, the reasoning goes.

But this doesn't seem to be the case looking at Teladoc's recent third-quarter results. Here's why I believe the stock has a lot of potential in the long run.

Continue reading

Source Fool.com